The Lancet May 11; Bipolar disorder. The Lancet Apr 9; Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study. BMJ Nov 8; e 4. The characteristics and health needs of pregnant women with schizophrenia compared with bipolar disorder and affective psychoses. BMC Psychiatry Apr 17; 5. Perinatal episodes across the mood disorder spectrum.
Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period. The Lancet Nov 15; Am J Psychiatry Feb 1; 2 Prevention of postpartum psychosis and mania in women at high risk. Am J Psychiatry Jun; 6 Changes in drug disposition of lithium during pregnancy: a retrospective observational study of patient data from two routine therapeutic drug monitoring services in Norway. BMJ Open Mar 1;7 3 :e Unplanned pregnancies and reproductive health among women with bipolar disorder.
J Affect Disord Jun 1; Antiepileptic drugs during pregnancy in primary care: a UK population based study. PLoS One ;7 12 : e Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol Jun;30 6 Risks and benefits of psychotropic medication in pregnancy: cohort studies based on UK electronic primary care health records.
International Guideline Library — Guidelines International Network
Health Technol Assess Mar;20 23 Clinical Guideline London: NICE; Lithium: a review of pharmacology, clinical uses, and toxicity. Eur J Pharmacol Oct 5; Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. Am J Psychiatry Jul; 7 Bergink V, Kushner SA. Lithium during pregnancy. Fetal, neonatal and developmental outcomes of lithium-exposed pregnancies.
Early Hum Dev 6;88 6 Three cases of lithium exposure and exclusive breastfeeding. Arch Womens Ment Health Feb;15 1 Mood stabilizers and antipsychotics during breastfeeding: Focus on bipolar disorder. Eur Neuropsychopharmacol Oct;26 10 Developmental effects of antiepileptic drugs and the need for improved regulations. Neurology Jan 19;86 3 Adverse drug reactions induced by valproic acid. Clin Biochem Oct;46 15 Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.
JAMA Apr 24; 16 Lamotrigine use in pregnancy and risk of orofacial cleft and other congenital anomalies. Neurology May 3;86 18 Lamotrigine dosing for pregnant patients with bipolar disorder. Am J Psychiatry Nov; 11 Antiepileptic drugs and breastfeeding. Ital J Pediatr Aug 28; Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy. Obstet Gynecol May; 5 PLoS One Jul 10;10 7 : e Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study.
BMJ Open Jul 13;3 7 : e A prospective cohort study of antipsychotic medications in pregnancy: the first pregnancies and one year old babies. PLoS One May 2;9 5 : e Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry Aug;69 8 A review of the safety of clozapine during pregnancy and lactation. Arch Womens Ment Health Feb;20 1 Antipsychotic drug use in pregnancy: high dimensional, propensity matched, population based cohort study.
BMJ May 13; h Uguz F. J Clin Psychopharmacol Jun;36 3 Antidepressant drug effects and depression severity. Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and ISRS pharmacotherapy.
Antidepressants plus benzodiacepines for mayor depression. Antidepressants and fracture risk in older adults: a comparative safety analysis. Clin Pharmacol Ther. Am J Epidemiol. Second-generation antidepres-sants in the pharmacologic treatment of adult depression: an update of the comparative effectiveness review. Ag Healthcare Res Qual. Comparative risk for harms of second-generation antidepressants: a systematic review and meta-analysis.
Drug Saf. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Case management for depression by health care assistants in small primary care practices a cluster randomized trial. Ann Intern Med.
Meta-analysis of relapse prevention antidepressant trial in depressive disorders. Aust New Zeal J Psychiatry. Amitriptyline for depression. Cost-effectiveness of brief psychodynamic-interpersonal therapy in high utilisers of psychiatric services. Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study. Int Clin Psychopharmacol.
*18927/0606* QuickSilver™ Bipolar Coagulation ... - Cook Medical
Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants. Psychiatr Serv. Clinical psychological tests useful for differentiating depressive state with Alzheimer's disease from major depression of the elderly. Heirs M, Dean ME. Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Exercise therapy for depression in middle-aged and older adults: predictors of early dropout and treatment failure. Health Psychol. Exercise and pharmacotherapy in patients with major depression: one-year follow-up of the SMILE study. Prevention of relapse following cognitive therapy vs. Treatment attitudes and adherence of psychiatric patients with major depressive disorder: A five-year prospective study. How much cognitive therapy, for which patients, will prevent depressive relapse? Jick S, Li L. Antidepressant drug use and risk of venous thromboembolism. Jindal RD.
Insomnia in patients with depression: some pathophysiological and treatment considerations. CNS Drugs. Childhood neglect and abuse as predictors of antidepressant response in adult depression. Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. Management of depression in UK general practice in relation to scores on depression severity questionnaires: analysis of medical record data. Kennedy SH, Emsley R. Placebo-controlled trial of agomelatine in the treatment of major depressive disorder.
A Double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. Pharmacoepidemiol Drug Saf. Relation-ship between a history of a suicide attempt and treatment outcomes in patients with depression. A randomised, controlled study on the effects of a short-term endurance training programme in patients with major depression. Br J Sports Med. The course of adverse effects of nortriptyline and venlafaxine in elderly patients with major depression.
J Am Geriatr Soc. Mindfulness-based cognitive therapy to prevent relapse in recurrent depression.
Treatment preference, engagement, and clinical improvement in pharmacotherapy versus psychotherapy for depression. Behav Res Ther. Unemployment, depressiveness and disability retirement: a follow-up study of the Finnish HeSSup population sample. Benzodiazepines and the risk of urinary incontinence in frail older persons living in the community. Exercise in prevention and treatment of anxiety and depression among children and young people. Cochrane Database Syst. Complementary use of tai chi chih augments escitalopram treatment of geriatric depression: a randomized controlled trial.
To continue, please check the box below:
Am J Geriatr Psychiatry. Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders. A systematic review of randomized controlled trials of acupuncture in the treatment of depression.
- Its Not Cricket: Skullduggery, Sharp Practice and Downright Cheating in the Noble Game.
- DepresiÃ³n y personalidad : desafÃos clÃnicos y conceptuales.
- Community care and schizophrenia.
- Spicy Confessions 2!
Work performance of employees with depression: the impact of work stressors. J Health Promot. St John's wort for major depression. Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales. Med Clin Barc. Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depres-sion. Measuring depression outcome with a brief self-report instrument: sensitivity to change of the Patient Health Questionnaire PHQ Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects.